DIZON’S FARMS FRESH HABIT COMLD PRESSED JUICE – JUST BEAT IT
LEMON GRASS ICED TEA
The FDA has warned establishments against selling these products.
“All concerned establishments are warned not to distribute violative food products until they have been issued the appropriate authorization, a License to Operate (LTO) for the establishment, and a CPR for the food products,” according to the FDA.
They also advised the public to always check if a food product or food supplement is registered with the FDA through their website (www.fda.gov.ph).—AAC
MANILA, Philippines — The Food and Drug Administration (FDA) on Wednesday (September 16) issued a warning against the purchase and consumption of several unregistered food and food supplements including a popular brand of liver spread.
According to its advisory dated August 26 and released only on September 16, the following products have no certificate of product registration issued and therefore unregistered in the agency:
Reno Brand Liver Spread
Miracle White Advance Whitening Capsules Food Supplement
Samantha’s Dips And Sauce Spanish Sardines Paste Sauce
“Since these unregistered food products and food supplements have not gone through the evaluation process of the FDA, the agency cannot assure its quality and safety,” the advisory said.
The FDA cited the provision of the Food and Drug Administration Act of 2009, which states that “the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising or sponsorship of health products without the proper authorization is prohibited.”
The agency also warned establishments not to distribute, advertise or sell the said violative food products until a proper certificate of registration is issued.
The Food and Drug Administration (FDA) has clarified that the traditional Chinese medicine, Lian Hua Qin Weng, is not registered in the Philippines as a product for coronavirus disease (COVID-19).
Although Lian Hua Qin Weng is used as a COVID-19 treatment in China and other countries, it is not registered for the same purpose in the Philippines, according to FDA Director General Eric Domingo.
“Dito sa Pilipinas approved natin siya as traditional-use herbal product (Here in the Philippines, it is approved as traditional-use herbal product) that helps remove toxins, invasion of the lungs including symptoms such as fever, cold, muscle soreness, stuffy and runny nose. Kasi iyong mga traditional medicines ang tini-treat niyan symptoms, alleviate symptoms. Hindi talaga siya directed to one particular illness, (Because these traditional medicines treat or alleviate symptoms. It is not really directed to one particular illness),” he said.
On Wednesday (August 12), the Chinese Embassy released a statement describing Lian Hua Qin Weng as a treatment for moderate and mild cases of COVID-19 in China.
However, in the Philippines, Domingo said the medicine still needs to undergo clinical trials and cannot be labeled as a treatment for COVID-19.
“Dito sa atin ang traditional medicine hindi natin siya ina-approve for particular illnesses […] hindi siya pwedeng i-label sa atin as treatment for COVID-19. Hindi siya pwedeng ibenta as that dito sa Pilipinas, (Here, traditional medicine is not approved for particular illnesses […] we cannot label it as treatment for COVID-19. It cannot be sold here in the Philippines as such),” he added.
The FDA official also explained that the medicine is a prescription drug and will not be sold over-the-counter. The FDA also warned the public not to buy Lian Hua Qin Weng online.
“Kailangan magpatingin sa doctor. Mag-reseta at pwede lang siyang ibenta sa mga licensed pharmacies or licensed retail outlets, (One needs to consult a doctor. A prescription is needed and the medicine can only be sold at licensed pharmacies or licensed retail outlets)” Domingo said. AAC (with reports from Aiko Miguel)
MANILA, Philippines — The Food and Drug Administration (FDA) has approved a traditional Chinese drug for the treatment of mild coronavirus disease 2019 (COVID-19).
According to the Certificate of Product Registration released by the FDA, Lian Hua Qing Wen “has been found to conform with the requirements and standards for marketing authorization for pharmaceutical products per existing regulations in force as of date hereof.”
Lian Hua Qing Wen, produced by traditional Chinese medicine manufacturer Shijiazhuang Yiling Pharmaceutical Co. Ltd., was approved for use in the Philippines last Friday (August 7).
In a statement, the Chinese Embassy in the Philippines said the approval was a welcome development for them as “this marks an important progress in the entry of TCM products into the Philippine market.”
The statement added that the said medicine is an approved COVID-19 treatment for mild and moderate cases in China.
The embassy added that the drug has also been approved in Hong Kong, Macau, Brazil, Indonesia, Canada, Mozambique, Romania, Thailand, Ecuador, Singapore, and Laos.
“It is our sincere hope that its entrance into the Philippine market will contribute to the fight against the spread of COVID-19 in this country and help the patients with mild and moderate symptoms recover,” it added.
The embassy, however, advised consumers to purchase and consume authentic traditional Chinese medicine only.
The Embassy also hopes that “TCM would play a bigger role to support the efforts of the Philippine government and its people to fight against COVID-19 until the final victory.” — /mbmf
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.